Rida Zainab et al. 2026. A Randomized Trial of miRNA-34a-Based Therapy for Chemosensitization in Triple-Negative Breast Cancer Patients. Journal of Health, Wellness and Community Research. 4, 5 (Mar. 2026), 1–7. DOI:https://doi.org/10.61919/hxwqyv32.